Single-cell RNA sequencing (scRNA-seq) is a cutting-edge technology that allows researchers to analyze the gene expression profiles of individual cells within a tissue or sample. The scRNA-seq solution comprises a combination of laboratory protocols, sequencing platforms, and computational tools specifically designed for the analysis of single-cell transcriptomes.
The global market for Single Cell RNA Sequencing Solution was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global market for single-cell RNA sequencing solutions has been experiencing significant growth in recent years. The adoption of scRNA-seq technology has revolutionized the field of genomics and biomedical research, allowing researchers to gain unprecedented insights into cellular heterogeneity and gene expression at the single-cell level. The continuous advancements in genomic research and the growing need for in-depth analysis of individual cells have driven the demand for scRNA-seq solutions. scRNA-seq has found applications in various fields, including cancer research, immunology, neuroscience, stem cell research, and precision medicine, further contributing to its market growth. The global market for single-cell RNA sequencing solutions is expected to continue its rapid growth in the coming years. Advancements in technology, improvements in data analysis tools, and the declining costs of sequencing are likely to drive wider adoption across research institutions and industries. Additionally, the application of scRNA-seq in clinical settings and its potential integration with other omics technologies may further expand its market reach.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Single Cell RNA Sequencing Solution, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Single Cell RNA Sequencing Solution by region & country, by Type, and by Application.
The Single Cell RNA Sequencing Solution market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cell RNA Sequencing Solution.
Market Segmentation
By Company
TAKARA BIO
BioCat GmbH
Thermo Fisher Scientific
Roche Holding AG
PerkinElmer
Dolomite Bio
Illumina
Witec AG
10x Genomics, Inc
Oxford Nanopore Technologies
QIAGEN
LC Sciences
Pacific Biosciences
Scipio bioscience
CD Genomics
Segment by Type:
Equipment
Service
Software
Segment by Application
Research Institutions
Bioscience Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Single Cell RNA Sequencing Solution manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Single Cell RNA Sequencing Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Single Cell RNA Sequencing Solution in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Single Cell RNA Sequencing Solution Product Introduction
1.2 Global Single Cell RNA Sequencing Solution Market Size Forecast
1.3 Single Cell RNA Sequencing Solution Market Trends & Drivers
1.3.1 Single Cell RNA Sequencing Solution Industry Trends
1.3.2 Single Cell RNA Sequencing Solution Market Drivers & Opportunity
1.3.3 Single Cell RNA Sequencing Solution Market Challenges
1.3.4 Single Cell RNA Sequencing Solution Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Single Cell RNA Sequencing Solution Players Revenue Ranking (2023)
2.2 Global Single Cell RNA Sequencing Solution Revenue by Company (2019-2024)
2.3 Key Companies Single Cell RNA Sequencing Solution Manufacturing Base Distribution and Headquarters
2.4 Key Companies Single Cell RNA Sequencing Solution Product Offered
2.5 Key Companies Time to Begin Mass Production of Single Cell RNA Sequencing Solution
2.6 Single Cell RNA Sequencing Solution Market Competitive Analysis
2.6.1 Single Cell RNA Sequencing Solution Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Single Cell RNA Sequencing Solution Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cell RNA Sequencing Solution as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Equipment
3.1.2 Service
3.1.3 Software
3.2 Global Single Cell RNA Sequencing Solution Sales Value by Type
3.2.1 Global Single Cell RNA Sequencing Solution Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Single Cell RNA Sequencing Solution Sales Value, by Type (2019-2030)
3.2.3 Global Single Cell RNA Sequencing Solution Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Institutions
4.1.2 Bioscience Companies
4.1.3 Others
4.2 Global Single Cell RNA Sequencing Solution Sales Value by Application
4.2.1 Global Single Cell RNA Sequencing Solution Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Single Cell RNA Sequencing Solution Sales Value, by Application (2019-2030)
4.2.3 Global Single Cell RNA Sequencing Solution Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Single Cell RNA Sequencing Solution Sales Value by Region
5.1.1 Global Single Cell RNA Sequencing Solution Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Single Cell RNA Sequencing Solution Sales Value by Region (2019-2024)
5.1.3 Global Single Cell RNA Sequencing Solution Sales Value by Region (2025-2030)
5.1.4 Global Single Cell RNA Sequencing Solution Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Single Cell RNA Sequencing Solution Sales Value, 2019-2030
5.2.2 North America Single Cell RNA Sequencing Solution Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Single Cell RNA Sequencing Solution Sales Value, 2019-2030
5.3.2 Europe Single Cell RNA Sequencing Solution Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Single Cell RNA Sequencing Solution Sales Value, 2019-2030
5.4.2 Asia Pacific Single Cell RNA Sequencing Solution Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Single Cell RNA Sequencing Solution Sales Value, 2019-2030
5.5.2 South America Single Cell RNA Sequencing Solution Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Single Cell RNA Sequencing Solution Sales Value, 2019-2030
5.6.2 Middle East & Africa Single Cell RNA Sequencing Solution Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Single Cell RNA Sequencing Solution Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Single Cell RNA Sequencing Solution Sales Value
6.3 United States
6.3.1 United States Single Cell RNA Sequencing Solution Sales Value, 2019-2030
6.3.2 United States Single Cell RNA Sequencing Solution Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Single Cell RNA Sequencing Solution Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Single Cell RNA Sequencing Solution Sales Value, 2019-2030
6.4.2 Europe Single Cell RNA Sequencing Solution Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Single Cell RNA Sequencing Solution Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Single Cell RNA Sequencing Solution Sales Value, 2019-2030
6.5.2 China Single Cell RNA Sequencing Solution Sales Value by Type (%), 2023 VS 2030
6.5.3 China Single Cell RNA Sequencing Solution Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Single Cell RNA Sequencing Solution Sales Value, 2019-2030
6.6.2 Japan Single Cell RNA Sequencing Solution Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Single Cell RNA Sequencing Solution Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Single Cell RNA Sequencing Solution Sales Value, 2019-2030
6.7.2 South Korea Single Cell RNA Sequencing Solution Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Single Cell RNA Sequencing Solution Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Single Cell RNA Sequencing Solution Sales Value, 2019-2030
6.8.2 Southeast Asia Single Cell RNA Sequencing Solution Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Single Cell RNA Sequencing Solution Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Single Cell RNA Sequencing Solution Sales Value, 2019-2030
6.9.2 India Single Cell RNA Sequencing Solution Sales Value by Type (%), 2023 VS 2030
6.9.3 India Single Cell RNA Sequencing Solution Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 TAKARA BIO
7.1.1 TAKARA BIO Profile
7.1.2 TAKARA BIO Main Business
7.1.3 TAKARA BIO Single Cell RNA Sequencing Solution Products, Services and Solutions
7.1.4 TAKARA BIO Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.1.5 TAKARA BIO Recent Developments
7.2 BioCat GmbH
7.2.1 BioCat GmbH Profile
7.2.2 BioCat GmbH Main Business
7.2.3 BioCat GmbH Single Cell RNA Sequencing Solution Products, Services and Solutions
7.2.4 BioCat GmbH Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.2.5 BioCat GmbH Recent Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Profile
7.3.2 Thermo Fisher Scientific Main Business
7.3.3 Thermo Fisher Scientific Single Cell RNA Sequencing Solution Products, Services and Solutions
7.3.4 Thermo Fisher Scientific Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.3.5 Roche Holding AG Recent Developments
7.4 Roche Holding AG
7.4.1 Roche Holding AG Profile
7.4.2 Roche Holding AG Main Business
7.4.3 Roche Holding AG Single Cell RNA Sequencing Solution Products, Services and Solutions
7.4.4 Roche Holding AG Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.4.5 Roche Holding AG Recent Developments
7.5 PerkinElmer
7.5.1 PerkinElmer Profile
7.5.2 PerkinElmer Main Business
7.5.3 PerkinElmer Single Cell RNA Sequencing Solution Products, Services and Solutions
7.5.4 PerkinElmer Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.5.5 PerkinElmer Recent Developments
7.6 Dolomite Bio
7.6.1 Dolomite Bio Profile
7.6.2 Dolomite Bio Main Business
7.6.3 Dolomite Bio Single Cell RNA Sequencing Solution Products, Services and Solutions
7.6.4 Dolomite Bio Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.6.5 Dolomite Bio Recent Developments
7.7 Illumina
7.7.1 Illumina Profile
7.7.2 Illumina Main Business
7.7.3 Illumina Single Cell RNA Sequencing Solution Products, Services and Solutions
7.7.4 Illumina Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.7.5 Illumina Recent Developments
7.8 Witec AG
7.8.1 Witec AG Profile
7.8.2 Witec AG Main Business
7.8.3 Witec AG Single Cell RNA Sequencing Solution Products, Services and Solutions
7.8.4 Witec AG Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.8.5 Witec AG Recent Developments
7.9 10x Genomics, Inc
7.9.1 10x Genomics, Inc Profile
7.9.2 10x Genomics, Inc Main Business
7.9.3 10x Genomics, Inc Single Cell RNA Sequencing Solution Products, Services and Solutions
7.9.4 10x Genomics, Inc Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.9.5 10x Genomics, Inc Recent Developments
7.10 Oxford Nanopore Technologies
7.10.1 Oxford Nanopore Technologies Profile
7.10.2 Oxford Nanopore Technologies Main Business
7.10.3 Oxford Nanopore Technologies Single Cell RNA Sequencing Solution Products, Services and Solutions
7.10.4 Oxford Nanopore Technologies Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.10.5 Oxford Nanopore Technologies Recent Developments
7.11 QIAGEN
7.11.1 QIAGEN Profile
7.11.2 QIAGEN Main Business
7.11.3 QIAGEN Single Cell RNA Sequencing Solution Products, Services and Solutions
7.11.4 QIAGEN Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.11.5 QIAGEN Recent Developments
7.12 LC Sciences
7.12.1 LC Sciences Profile
7.12.2 LC Sciences Main Business
7.12.3 LC Sciences Single Cell RNA Sequencing Solution Products, Services and Solutions
7.12.4 LC Sciences Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.12.5 LC Sciences Recent Developments
7.13 Pacific Biosciences
7.13.1 Pacific Biosciences Profile
7.13.2 Pacific Biosciences Main Business
7.13.3 Pacific Biosciences Single Cell RNA Sequencing Solution Products, Services and Solutions
7.13.4 Pacific Biosciences Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.13.5 Pacific Biosciences Recent Developments
7.14 Scipio bioscience
7.14.1 Scipio bioscience Profile
7.14.2 Scipio bioscience Main Business
7.14.3 Scipio bioscience Single Cell RNA Sequencing Solution Products, Services and Solutions
7.14.4 Scipio bioscience Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.14.5 Scipio bioscience Recent Developments
7.15 CD Genomics
7.15.1 CD Genomics Profile
7.15.2 CD Genomics Main Business
7.15.3 CD Genomics Single Cell RNA Sequencing Solution Products, Services and Solutions
7.15.4 CD Genomics Single Cell RNA Sequencing Solution Revenue (US$ Million) & (2019-2024)
7.15.5 CD Genomics Recent Developments
8 Industry Chain Analysis
8.1 Single Cell RNA Sequencing Solution Industrial Chain
8.2 Single Cell RNA Sequencing Solution Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Single Cell RNA Sequencing Solution Sales Model
8.5.2 Sales Channel
8.5.3 Single Cell RNA Sequencing Solution Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TAKARA BIO
BioCat GmbH
Thermo Fisher Scientific
Roche Holding AG
PerkinElmer
Dolomite Bio
Illumina
Witec AG
10x Genomics, Inc
Oxford Nanopore Technologies
QIAGEN
LC Sciences
Pacific Biosciences
Scipio bioscience
CD Genomics
听
听
*If Applicable.
